3

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: July 13, 2011
Period of Report: July 12, 2011
Accession Number: 0001514955-11-000026

View Document ↗ View on SEC.gov ↗